Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Stephen Ellis
Icahn School of Medicine at Mount Sinai, Department: Genetics
Should you be removed from our database? Contact us at [email protected]. Read more below.
Ontomics
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Stephen Ellis (a Co-Investigator in this study) is a named co-inventor on a patent application and has developed software and know-how related to CLIPMERGE, a medical decision-support software platform that collects, aggregates, and displays clinical data. The platform allows for personalized medical decision making. The CLIPMERGE tool is being utilized in the current study. The intellectual property related to the software and know-how has been licensed by the Icahn School of Medicine to Ontomics, a privately-held company in which Mr. Ellis is an equity owner. If the CLIPMERGE technology is commercially successful, Mr. Ellis and Icahn School of Medicine may benefit financially.
Incorporating genomics into the clinical care of diverse NYC children
The NYCKidSeq program will assess the clinical utility of genomic medicine in three broad areas of pediatric disorders, while engaging a range of providers and community members to overcome the well-documented barriers to inclusion of under-served and under-represented populations in genomic research. We will also test, analyze, and implement web-based technologies to enhance education and counseling about genomic medicine, and communicate findings to carers at all levels of expertise, in two health systems. Overall, this work will inform the genomics and clinical communities about how to implement genomic medicine in a diverse population in a clinically useful, technologically savvy, culturally sensitive, and ethically sound manner. �
Filed on August 28, 2017.
Tell us what you know about Stephen Ellis's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Stephen Ellis”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Stephen Ellis | Icahn School of Medicine at Mount Sinai | Conflict of Interest | Ontomics | $0 - $4,999 |
| Stephen Ellis | Icahn School of Medicine at Mount Sinai | Conflict of Interest | Ontomics | $0 - $4,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.